EHMT2 and leukemia: In our case, the use of JIB-04 demethylase inhibitor, by enhancing the coactivator function of G9a and GLP, selectively enhances the effect of GC on leukemia cell death, while apparently having no effect on genes involved in regulating other physiological pathways.